Physician profile
Vincent Moss
NPI 1396799565
$5,340.74
in general payments reported to CMS, 2019-2025
11 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2022: $621 · 2023: $3,473 · 2024: $237 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $888 · Travel and Lodging: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $887.68 |
| Travel and Lodging | $648.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,145.96 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $355.69 | 2022-2025 | Arista, Surgiphor, Phasix Mesh |
| Abbott Laboratories | $241.20 | 2019 | |
| Tela Bio, INC. | $193.80 | 2024 | Ovitex 2s |
| Medtronic, INC. | $147.02 | 2023 | Endoflip, Signia |
| W. L. Gore & Associates, INC. | $77.31 | 2019 | |
| Covidien LP | $54.02 | 2019 | |
| Integra Lifesciences Corporation | $52.08 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $35.30 | 2019 | |
| Ethicon US, LLC | $23.57 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.79 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.